A role for PKC overactivity in this reduced relaxant activity of PDE5 inhibitors in diabetes was supported by the lack of influence of PKC activation on sildenafil-induced relaxations in the CC of diabetic ED patients, while only in these tissues, PKC inhibition resulted in enhanced relaxation in response to sildenafil. The gene discussed is PDE5A; the disease is diabetes mellitus.